Carmat
ALCAR
Company Profile
Business description
Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.
Contact
36, avenue de l’Europe
Immeuble l’Etendard Energy III
Velizy Villacoublay78140
FRAT: +33 139456450
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
182
Stocks News & Analysis
stocks
Will China strong arm BHP into lower iron ore prices?
Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks
Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27
Charts from the Australian Dividend Outlook show the sectors where they are abundant.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,276.60 | 19.90 | -0.21% |
| CAC 40 | 8,041.36 | 18.77 | -0.23% |
| DAX 40 | 24,611.25 | 14.12 | 0.06% |
| Dow JONES (US) | 46,290.95 | 310.83 | -0.67% |
| FTSE 100 | 9,509.40 | 39.47 | -0.41% |
| HKSE | 26,752.59 | 76.87 | -0.29% |
| NASDAQ | 22,985.24 | 58.13 | -0.25% |
| Nikkei 225 | 48,580.44 | 845.45 | 1.77% |
| NZX 50 Index | 13,570.86 | 2.38 | 0.02% |
| S&P 500 | 6,726.25 | 27.47 | -0.41% |
| S&P/ASX 200 | 8,969.80 | 25.20 | -0.28% |
| SSE Composite Index | 3,933.97 | 51.20 | 1.32% |